NeuroOne Medical Technologies Corporation

Equities

NMTC

US64130M2098

Advanced Medical Equipment & Technology

Delayed Nasdaq 10:06:18 2024-04-25 am EDT 5-day change 1st Jan Change
1.15 USD -0.86% Intraday chart for NeuroOne Medical Technologies Corporation +0.88% -27.22%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
NeuroOne Medical Technologies Corporation Initiates Limited Commercial Launch of OneRF Ablation System CI
Transcript : NeuroOne Medical Technologies Corporation, Q1 2024 Earnings Call, Feb 13, 2024
NeuroOne Medical Technologies Corporation Reports Earnings Results for the First Quarter Ended December 31, 2023 CI
Transcript : NeuroOne Medical Technologies Corporation, Q4 2023 Earnings Call, Dec 14, 2023
NeuroOne Medical Technologies Corporation Reports Earnings Results for the Full Year Ended September 30, 2023 CI
NeuroOne Gets FDA Clearance to Market OneRF Ablation System; Shares Fall MT
NeuroOne Medical Technologies Corporation Receives FDA 510(K) Clearance to Market its OneRF(TM) Ablation System CI
NeuroOne Medical Technologies Gets Notice of Allowance for Drug Delivery Patent MT
NeuroOne Medical Technologies Corporation Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe CI
NeuroOne Medical Technologies Names Christopher Volker as Chief Operating Officer MT
NeuroOne Medical Technologies Corporation Appoints Christopher R. Volker as Chief Operating Officer CI
NeuroOne Medical Technologies Corporation Provides Progress Update on FDA 510(k) Submission for OneRF?? Ablation System CI
Alliance Global Partners Trims Price Target on NeuroOne Medical Technologies to $2.20 From $3.25, Maintains Buy Rating MT
Transcript : NeuroOne Medical Technologies Corporation, Q3 2023 Earnings Call, Aug 14, 2023
NeuroOne Medical Technologies Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023 CI
Top Midday Decliners MT
Top Premarket Decliners MT
NeuroOne Medical Technologies Proposes Common Stock Offering -- Shares Sink Premarket MT
NeuroOne Medical Technologies Shares Rise 4.9% After 510(k) Submission DJ
NeuroOne Medical Technologies Corporation Submits 510(K) Application to FDA for OneRF™ Ablation System CI
NeuroOne Medical Technologies Corporation Announces First Clinical Case Using Evo® sEEG Electrode in Robotic Neurosurgery CI
Transcript : NeuroOne Medical Technologies Corporation, Q2 2023 Earnings Call, May 11, 2023
NeuroOne Medical Technologies Corporation Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023 CI
Top Premarket Gainers MT
NeuroOne® Successfully Completes Initial Animal Implant of Novel Thin Film Paddle Lead for Spinal Cord Stimulation CI
Chart NeuroOne Medical Technologies Corporation
More charts
NeuroOne Medical Technologies Corporation is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders. The Company is focused on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, spinal cord stimulation, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure and artificial intelligence. Its Evo cortical electrode technology records, monitors, and stimulates brain tissue on the surface of the brain. Its products include strip/grid, depth electrodes (sEEG Products) and electrode cable assembly products.
More about the company
  1. Stock Market
  2. Equities
  3. NMTC Stock
  4. News NeuroOne Medical Technologies Corporation
  5. NeuroOne Medical Technologies : Partners with RBC Medical Over Radiofrequency Generator Development